首页|期刊导航|医学分子生物学杂志|导致肥胖的单基因研究进展

导致肥胖的单基因研究进展OA

Research Progress on Single Genes Associated with Obesity

中文摘要英文摘要

单基因肥胖是由单个基因突变引起的肥胖,约占儿童和成人肥胖的2%~10%.自瘦素及其受体基因被鉴定以来,已发现超过85种单基因肥胖形式,绝大多数致病基因集中于下丘脑瘦素—黑皮质素信号通路,该通路是中枢调控食欲与能量平衡的核心枢纽.黑皮质素 4 受体(melanocortin 4 receptor,MC4R)突变是早发性单基因肥胖最常见病因基因,占所有单基因肥胖病例的1/4以上.近年来,随着全外显子测序和大规模队列研究的推进,TUB、ADCY3、ALMS1等新基因陆续被鉴定,极大拓展了单基因肥胖的遗传谱系.在临床治疗方面,基于遗传机制的精准药物已取得突破性进展:MC4R激动剂Setmelanotide已获批用于POMC、PCSK1、LEPR缺乏症及巴德-毕德氏综合征等特定遗传亚型,口服MC4R校正剂CGX-926已进入Ⅰ期临床试验.文章系统综述单基因肥胖的致病基因谱系、分子机制、遗传检测策略及靶向治疗进展,旨在为临床精准诊疗提供理论依据.

Monogenic obesity is obesity caused by a mutation in a single gene,accounting for about 2%to 10%of obesity in children and adults.Since the identification of the leptin gene and its receptor,over 85 forms of monogenic obesity have been discovered,with the vast majority of patho-genic genes concentrated in the hypothalamic leptin-melanocortin signaling pathway,which is a key hub in the central regulation of appetite and energy balance.Mutations in the MC4R gene are the most common cause of monogenic obesity,accounting for more than a quarter of all cases.In recent years,with the advancement of whole-exome sequencing and large-scale cohort studies,new genes such as TUB,ADCY3,and ALMS1 have been identified,greatly expanding the genetic spectrum of monogenic obesity.In terms of clinical treatment,precision drugs based on genetic mechanisms have made breakthrough progress:the MC4R agonist setmelanotide has been approved for specific genetic subtypes such as POMC,PCSK1,LEPR deficiencies,and Bardet-Biedl syndrome,while the oral MC4R modulator CGX-926 has entered Phase I clinical trials.This article provides a sys-tematic overview of the pathogenic gene spectrum,molecular mechanisms,genetic testing strate-gies,and targeted treatment progress in monogenic obesity,aiming to provide a theoretical basis for precise clinical diagnosis and treatment.

冯钟徽;黎友琴;冯政民;邓丽;吕凤如;李尔干;廖海;文君;刘雁军

成都市第三人民医院 肥胖与代谢医工结合实验室 成都市,610000西南交通大学 医学院 成都市,610000西南交通大学 生命科学与工程学院 成都市,610000西南交通大学 生命科学与工程学院 成都市,610000西南交通大学 生命科学与工程学院 成都市,610000西南民族大学畜牧兽医学院 成都市,610000西南交通大学 生命科学与工程学院 成都市,610000成都市第三人民医院 肝胆胰外科 成都市,610000成都市第三人民医院 肥胖与代谢医工结合实验室 成都市,610000

医药卫生

单基因肥胖瘦素-黑皮质素通路黑皮质素4受体遗传检测靶向治疗

monogenic obesityleptin-melanocortin pathwaymelanocortin 4 receptorgenetic testingtargeted therapy

《医学分子生物学杂志》 2026 (5)

577-586,10

国家自然科学基金(No.82202007),成都市第三人民医院临床研究项目(No.2023PI22、No.CSY-YN-01-2023-039),四川省自然科学基金(No.2023NSFSC0739) This work was supported by grants from the National Natural Science Foundation of China(No.82202007),the Third People's Hospital of Chengdu Clinical Research Program(No.2023PI22,No.CSY-YN-01-2023-039),the Natural Science Foundation of Sichuan Province(No.2023NSFSC0739).

10.3870/j.issn.1672-8009.2026.05.013

评论